The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor

Conditions:   Doxorubicin Adverse Reaction;   Cardiomyopathies, Secondary;   Breast Cancer Intervention:   Sponsor:   Rush University Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials